Stay Connected
Join us on Facebook Follow us on linked in Follow us on YouTube Follow us on Vimeo
Oncology CRO for clinical drug research expertise in all cancers
Oncology Clinical Research
request info
First Name*:
Last Name*:
Company*:
Email*:
Leave a Message:


Please enter the security code


Find out how our medical, regulatory, and operational expertise in oncology clinical development can help with your next study or program.

Learn More

Oncology studies demand a specialized team who understands and can readily execute the scientific and regulatory issues that are most relevant to the program. Our oncology teams are built to work quickly, tactically and honestly with Sponsor and sites in a partnership philosophy. Focused oncology teams allow effective trial planning and execution from protocol development to database lock. Medpace works proactively to identify potential issues of concern, and provides solutions for the most efficient and successful trial.

With experience in trials from early through late phase development (Phase I – IV), including classic multi-cytotoxic agent and targeted and/or biologic therapy trials, the oncologic experts at Medpace deliver rapid and accurate results in trials of varied scope – from small, focused trials to large global studies.

There is an urgent need to develop new oncologic therapies. But oncology clinical trials are longer and more complex than those in any other therapeutic area. The complexity of development demands the right kind of research partner. Powerful solutions demand the thought leaders at Medpace.

Oncology clinical and regulatory experience

  • Solid tumors
  • Hematologic malignancy
  • Lung Cancer
  • Breast Cancer
  • Gastrointestinal cancer (including colorectal and non-colorectal cancer)
  • Genitourinary cancers (including prostate, renal and bladder cancer
  • Gynecologic cancers
  • CNS / Brain cancer
  • Head and neck cancer
  • Skin cancer including melanoma
  • Lymphoma
  • Leukemia including acute and chronic specific indications
  • Pediatric oncologi/hematologic indications
  • Palliative/supportive care